Publication: Hospice News
Article: Enclara VP Raymond Capella: Pharmacy Collaboration Essential to Compliance
Featuring: Raymond Capella, Vice President of Clinical and Analytical Service, Enclara Pharmacia
Hospices often face obstacles when it comes to determining the relatedness of medication and treatment to a patient’s terminal illness. Providers are reevaluating how they prescribe and deprescribe medications for patients nearing the end of life.
Hospices have come under closer scrutiny in recent years as the U.S. Centers for Medicare & Medicaid Services (CMS and the U.S. Department of Health & Human Services Office of the Inspector General (OIG) continue to take a hard look at issues such as recertifications and billing for services outside the hospice benefit, including medications. An increased focus on medication appropriateness comes with the new addendum to the election statement effective Oct. 1, even as the numbers of CMS audits are ticking upward.
Hospices now must provide Medicare beneficiaries with a written statement called a “Patient Notification of Hospice Non-Covered Items, Services, and Drugs” detailing the conditions, items, services or drugs that are determined to be unrelated to their terminal illness and conditions and not covered […] Continue Reading